A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

In A Nutshell Men have double the odds of presenting with stage III multiple myeloma compared to women, even after accounting ...

Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer multiple myeloma, according to interim results from a clinical trial conducted ...

The discovery that tissues use electricity to expel unhealthy cells is part of a surge of renewed interest in the currents ...

Jan. 12, 2026, San Francisco. Issued from the J.P. Morgan Healthcare Conference WARREN, N.J., Jan. 12, 2026 (GLOBE NEWSWIRE) ...

Explore how RPMI 1640 supports cancer and immunology research by providing essential nutrients for cell growth, metabolism, ...

A shift in the balance between two lipids – cholesterol and sphingomyelin – makes hybrid epithelial-mesenchymal cancer cells less responsive to certain chemotherapy drugs.

The relationship between inflammation and cancer represents one of the central paradoxes in modern tumor immunology. On one hand, chronic inflammation is a ...

A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...